DONATE

NTD activities in Africa in the COVID-19 era: the need for a ‘hybrid’ approach in COVID-endemic times

Not restarting mass drug administration (MDA) will not only enhance the risk of NTD transmission, but will fail to leverage behaviour change messaging on the importance of hand and face washing and improved sanitation – a common strategy for several NTDs that also reduces the risk of COVID-19 spread.

We believe that unless MDA and morbidity management activities resume, achievement of NTD targets as projected in the new WHO Roadmap (2020-2030) will be deferred, the aspirational goal of NTD programmes to enhance universal health coverage (UHC) jeopardised and the call to ‘leave no one behind’ a hollow one. Hence, we outline what implementing this approach, which aims to strengthen health systems, and facilitate integration and cross-sector collaboration, will look in the short, medium and long term.

Publication date: October 2020

Want to learn more about our work?

Sightsavers and NTDs

More on NTDs

A community drug distributor hands an elderly man medication to treat trachoma.
sightsavers_news

WHO report reveals millions no longer at risk from trachoma

The number of people at risk from trachoma has fallen by more than 12 million in a single year, according to a new report by the World Health Organization.

July 2024
A lab scientist in Nigeria examines samples under a microscope.
Sightsavers blog

How our research could help more than 50 million women

Sightsavers researchers are working to understand how we can care for women with female genital schistosomiasis, a devastating disease that affects millions of women in Africa.

Omosefe Osinoiki, June 2024
A female researcher speaks to a woman about her experience of female genital schistosomiasis.
Sightsavers blog

Why community collaboration is important in our research

Our research on female genital schistosomiasis has shown the need to establish a safe environment for participants when studying sensitive topics.

Omosefe Osinoiki, April 2024